Multiple myeloma immunoglobulin lambda translocations portend poor prognosis
Benjamin G. Barwick, Paola E. Neri, Nizar Jacques Bahlis, Ajay K. Nooka, Madhav V. Dhodapkar, David L. Jaye, Craig C. Hofmeister, Jonathan L. Kaufman, Vikas Anand Gupta, Daniel Auclair, Jonathan J. Keats, Sagar Lonial, Paula M. Vertino, Lawrence Boise
The paper identifies IgL translocations in multiple myeloma as a marker of poor prognosis, often misclassified as standard risk due to co-occurrence with hyperdiploidy.
Nature Communications · Apr 23, 2019Peer-reviewedGenomics